ALR TECHNOLOGIES INC. (OTCMKTS:ALRT) Files An 8-K Regulation FD DisclosureITEM 7.01REGULATION FD DISCLOSURE.
On August 27, 2018, ALR Technologies Inc. (“ALRT”) issued a press release announcing that it had entered into a Memorandum of Understanding with Aspire Cerebro Advertising Ltd. to co-market the ALRT Diabetes Solution in India.
A copy of this press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference into this item 9.01.
ITEM 9.01EXHIBITS AND FINANCIAL STATEMENTS.
| Exhibit | Document Description |
| 99.1 | Press Release. |
ALR TECHNOLOGIES INC. Exhibit…To view the full exhibit click here
About ALR TECHNOLOGIES INC. (OTCMKTS:ALRT)
ALR Technologies Inc. is a medical device company. The Company is engaged in providing remote monitoring and care facilitation for patients with diabetes. The Company focuses on commercializing its Heath-e-Connect System. The Company has developed a compliance monitoring system that will allow healthcare professionals to remotely monitor patient health conditions and provide patient health management. The Company’s products utilize Internet-based technologies to facilitate healthcare provider’s ability to monitor their patient’s health and ensure adherence to health maintenance activities. The Company’s Diabetes Care Facilitators and Health Data Monitors will track that data and based on clinician-approved protocols, will facilitate care interventions when patients show blood glucose readings that are out of an acceptable range or if they are failing to test their blood glucose as prescribed.
